| Literature DB >> 33236845 |
Dai-Zhu Lin1, Yu-Chien Kao1, Chiehfeng Chen2,3,4, Hsian-Jenn Wang2, Wen-Kuan Chiu2,5.
Abstract
Negative pressure wound therapy (NPWT), which has been applied in various medical specialties to accelerate wound healing, has been the object of a few investigations. We explored the effectiveness of NPWT and the possibility of its inclusion in burn management guidelines. Randomised controlled trials comparing NPWT with non-NPWT treatments for burn wounds were extracted from PubMed. For the risk of bias analysis, all included studies were evaluated according to the Cochrane risk of bias tool and the approaches outlined in the GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) Handbook. Outcomes such as graft take rate in the first week, infection rate, and overall complication rate were analysed. Six studies that included a total of 701 patients met our inclusion criteria. Qualitative analysis revealed that the NPWT group had a significantly better overall graft rate in the first week (P = 0.001) and a significantly lower infection rate (P = 0.04). No significant difference in the overall complication rate was found. Our results indicate that NPWT is a safe method for stimulating healing and lowering the infection rate of burn wounds. NPWT can be part of general burn management, and its incorporation into burn treatment guidelines is recommended.Entities:
Mesh:
Year: 2020 PMID: 33236845 PMCID: PMC7949461 DOI: 10.1111/iwj.13500
Source DB: PubMed Journal: Int Wound J ISSN: 1742-4801 Impact factor: 3.315
Characteristics of trials included in the systematic review
|
|
Outcomes of trials included in the systematic review
| Authors/Country | Graft Take Rate | Infection Rate | Overall Complication Rate | Major Complications |
|---|---|---|---|---|
| Bloemen et al (2012)/The Netherlands | Day 5 | None of the wounds were infected, pre‐ or postoperatively | Patients with complications (n, %) | 1. Contaminated wounds pre‐/post‐op: |
| (1) DS‐TNP = 94.8% | (1) DS‐TNP = 7 (33) | (1) DS‐TNP = 10/21 (48%)/10/14 (71%) | ||
| (2) DS = 92.4% | (2) DS = 7 (30) | (2) TNP = 5/21 (24%)/6/17 (35%) | ||
| (3) TNP = 94.2% | (3) TNP = 5 (23) | (3) DS = 10/22 (45%)/13/17 (76%) | ||
| (4) ST = 96.1% | (4) ST = 2 (10) | (4) ST = 8/18 (44%)/7/9 (78%) | ||
| 2. Patients re‐op (n, %): | ||||
| (1) DS‐TNP = 2 (10), (2) TNP = 1 (5), (3) DS = 3 (13), (4) ST = 1 (5) | ||||
| 3. Hematoma and graft loss: (1) DS‐TNP = 1, (2) TNP = 0, (3) DS = 2, (4) ST = 0 | ||||
| 4. Graft shift: (1) DS‐TNP = 2, (2) TNP = 2, (3) DS = 0, (4) ST = 0 | ||||
| 5. Graft loss (5%‐100%) (1) DS‐TNP = 2, (2) TNP = 3, (3) DS = 5, (4) ST = 2 | ||||
| 6. Postop bleeding: (1) DS‐TNP = 1, (2) TNP = 0, (3) DS = 0, (4) ST = 0 | ||||
| Hsiao et al (2016)/Taiwan |
Week 1 NPWT: 71.4% control: 85.7% | No wound infection was noted in any patients |
Itching (%) NPWT: 0 control: 7.1 | No unwanted event (such as seroma formation) and no formation of hypertrophic scar |
| Ibrahim et al (2019)/Egypt |
Wound surface area Percentage change ± SD (%) NPWT/MES/control (1) Pre‐treatment—Day 10: 27.8 ± 6.6/47.2 ± 7.2/15.7 ± 5.7 (2) Pre‐treatment—Day 21: 74.7 ± 16.4/85.4 ± 10.6/37.2 ± 10.4 | |||
| Liu et al (2016)/China |
Day 7/14/21 (%) NPWT: 40.6 ± 1.0/60.9 ± 1.5/90.6 ± 5.1 NPWT + ADM: 39.8 ± 1.2/77.1 ± 2.3/98.7 ± 1.7 ADM: 10.6 ± 0.3/55.9 ± 1.4/75.0 ± 1.8 |
Infected wounds/total wounds at day 21 NPW: 2/18 (0.11%) NPWT+ADM: 2/23 (0.08%) ADM: 8/11 (0.72%) |
Infected wounds/total wounds at day 21 NPW: 2/18 (0.11%) NPWT+ADM: 2/23 (0.08%) ADM: 8/11 (0.72%) | |
| Petkar et al (2011)/India |
Day 9 Percentage ± SD NPWT: 96.67% ± 3.554 control: 87.53% ± 8.733 | 1. Air leak: 5 in NPWT group | ||
| 2. Post‐operative day when dressing was discontinued for self‐massage with moisturiser was noted | ||||
| 3. No serious adverse effects in either group | ||||
| Wen et al (2017)/China |
Number/total NPWT: 6/225 (2.67%) control: 10/225 (4.44%) |
Number/total NPWT: 18/225 (8%) control: 32/225 (14.22%) |
Abbreviations: ADM, acellular dermal matrix; DS, dermal substitute; MES, microcurrent electrical stimulation; NPWT, negative pressure wound therapy; ST, standard treatment; STSG, split‐thickness skin graft; TNP, topical negative pressure.
FIGURE 1Flow chart of the study selection
FIGURE 2Forest plot and meta‐analysis showing the standard mean difference of graft take rate at week one between NPWT (negative pressure wound treatment) and control groups
FIGURE 3Forest plot and meta‐analysis showing mean difference of complication rate between NPWT (negative pressure wound treatment) and control groups
ÐRADE (grading of recommendations, assessment, development, and evaluation) assessment of the meta‐analysis
| Certainty Assessment | No of Patients | Effect | Certainty | Importance | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No of Studies | Study Design | Risk of Bias | Inconsistency | Indirectness | Imprecision | Other Considerations | NPWT | Conventional Treatment | Relative (95% CI) | Absolute (95% CI) | ||
|
| ||||||||||||
| 4 | Randomised trials | Not serious | Not serious | Not serious | Not serious | None | 120 | 85 | – | SMD 2.62 higher (1.01 higher to 4.22 higher) | ⊕⊕⊕⊕ HIGH | CRITICAL |
|
| ||||||||||||
| 2 | Randomised trials | Serious | Serious | Not serious | Not serious | None | 10/266 (3.8%) | 26/247 (10.5%) | OR 0.12 (0.02‐0.87) | 91 fewer per 1000 (from 103 fewer to 12 fewer) | ⊕⊕○○ LOW | CRITICAL |
|
| ||||||||||||
| 4 | Randomised trials | Serious | Serious | Not serious | Not serious | None | 41/346 (11.8%) | 55/321 (17.1%) | OR 0.59 (0.16‐2.17) | 63 fewer per 1000 (from 139 fewer to 138 more) | ⊕⊕○○ LOW | CRITICAL |
Abbreviations: CI, confidence interval; OR, odds ratio; SMD, standardised mean difference.
High risk of bias due to lack of blinding. None of them were able to blind the participants and personnel. Both RCTs' outcome assessors were not blinded for any outcomes.
The variability is substantial, but differences are between small and large beneficial effects.
Heterogeneity P = 0.01, I ^ 2 = 78%.
High risk of bias due to a lack of blinding. None of them were able to blind the participants and personnel. 1 RCT's outcome assessors were not blinded for any outcomes while 3 RCTs were unclear on it.
Heterogeneity P = 0.0001, I ^ 2=78%.